<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nefr</journal-id><journal-title-group><journal-title xml:lang="ru">Нефрология</journal-title><trans-title-group xml:lang="en"><trans-title>Nephrology (Saint-Petersburg)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1561-6274</issn><issn pub-type="epub">2541-9439</issn><publisher><publisher-name>Pavlov First Saint-Petersburg State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.24884/1561-6274-2018-22-5-64-70</article-id><article-id custom-type="elpub" pub-id-type="custom">nefr-1596</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ. КЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES. CLINICAL INVESTIGATIONS</subject></subj-group></article-categories><title-group><article-title>ОЦЕНКА ВЗАИМОСВЯЗИ УРОВНЯ VCAM-1 КРОВИ И КЛИНИКО- МОРФОЛОГИЧЕСКИХ ХАРАКТЕРИСТИК ХРОНИЧЕСКОГО ГЛОМЕРУЛОНЕФРИТА</article-title><trans-title-group xml:lang="en"><trans-title>EVALUATION OF THE INTERRELATIONS OF BLOOD VCAM-1 LEVEL AND CLINICO-MORPHOLOGICAL CHARACTERISTICS OF CHRONIC GLOMERULONEFRITIS</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Баяндурова</surname><given-names>К. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Bayaundurova</surname><given-names>K. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кафедра внутренних болезней №2</p><p>344022, г. Россия Ростов-на-Дону, пер. Нахичеванский, д. 29</p><p>врач-ординатор</p><p>Тел.: +7-988-257-76-67</p></bio><bio xml:lang="en"><p>Department of Internal Diseases №2, resident</p><p>344022, Russia Rostov-on-Don, the lane Nakhichevansky, 29</p><p>Phone: +7-988-257-76-67</p><p> </p></bio><email xlink:type="simple">karina1611994@gmal.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Батюшин</surname><given-names>М. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Batyushin</surname><given-names>M. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кафедра внутренних болезней №2</p><p>344022, Россия, г. Ростов-на-Дону, пер. Нахичеванский, д. 29</p><p>Проф. Батюшин Михаил Милайлович, д-р мед. наук</p><p>Тел.: +7-918-501-88-01</p></bio><bio xml:lang="en"><p>Department of Internal Diseases №2</p><p>344022, Rusia Rostov-on-Don, the lane Nakhichevansky, 29</p><p>Prof. Mikhail M. Batiushin MD, PhD, DMedSci.</p><p>Phone: +7-918-501-88-01</p></bio><email xlink:type="simple">batjushin-m@rambler.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сарвилина</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Sarvilina</surname><given-names>I. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>344022, Россия, г. Ростов-на-Дону, ул. Социалистическая, д. 74 Бизнес-центр «Купеческий двор», офис 1030</p><p>Тел.: 8(903) 436-48-66</p><p> </p></bio><bio xml:lang="en"><p>344111, Russia, Rostov-on-Don, str. Of 1st Konnoy Army, 3</p><p>MD, Unit of Pathology</p><p>Phone: +7(863) 252-19-30</p><p> </p></bio><email xlink:type="simple">isarvilina@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Антипова</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Antipova</surname><given-names>N. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>патологоанатомическое отделение</p><p>344022, Россия, г. Ростов-на-Дону, ул. 1-й Конной Армии, д. 3</p><p>Тел.: 8(918) 553-65-22</p></bio><bio xml:lang="en"><p>Pathology unit</p><p>344111, Russia, Rostov-on-Don, str. Of 1st Konnoy Army, 3</p><p>Phone: +7(918) 553-65-22</p></bio><email xlink:type="simple">ob2p@mail.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Синельник</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Sinel’nik</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>нефрологическое отделение</p><p>344022, Россия, г. Ростов-на-Дону, ул. 1-й Конной Армии, д. 3</p><p>Тел.: 8(863) 252-19-30</p></bio><bio xml:lang="en"><p>Nefrological unit</p><p>344111, Russia, Rostov-on-Don, str. Of 1st Konnoy Army, 3</p><p>Phone: +7(863) 252-19-30</p><p> </p></bio><email xlink:type="simple">ob2p@mail.ru</email><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Ростовский государственный медицинский университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Rostov State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Медицинский центр «Новомедицина»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Medical Center "Novomeditsina"</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Ростовская областная больница № 2</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Rostov Regional Hospital № 2</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>08</day><month>10</month><year>2018</year></pub-date><volume>22</volume><issue>5</issue><fpage>64</fpage><lpage>70</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Баяндурова К.М., Батюшин М.М., Сарвилина И.В., Антипова Н.В., Синельник Е.В., 2018</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="ru">Баяндурова К.М., Батюшин М.М., Сарвилина И.В., Антипова Н.В., Синельник Е.В.</copyright-holder><copyright-holder xml:lang="en">Bayaundurova K.M., Batyushin M.M., Sarvilina I.V., Antipova N.V., Sinel’nik E.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.nephrolog.ru/jour/article/view/1596">https://journal.nephrolog.ru/jour/article/view/1596</self-uri><abstract><p>Хронический гломерулонефрит характеризуется необратимым прогрессированием патологического процесса, который приводит к формированию терминальной почечной  недостаточности, значительно ухудшающей качество жизни пациента, приводящей к  дисфункции внутренних органов и повышающей риск преждевременной общей и сердечно-сосудистой смертности. В связи с этим актуальным становится поиск неинвазивных методов  оценки состояния почечной ткани, включающих в себя выявление белков, участвующих в  процессах почечного воспаления, фиброза, межклеточного взаимодействия.</p><sec><title>ЦЕЛЬ</title><p>ЦЕЛЬ: определить содержание в сыворотке крови больных с различными формами хронического гломерулонефрита (ХГН) сосудистой молекулы клеточной адгезии-1  (VCAM-1) и уточнить его взаимосвязь с развитием морфологических изменений в почечной ткани.</p></sec><sec><title>ПАЦИЕНТЫ И МЕТОДЫ</title><p>ПАЦИЕНТЫ И МЕТОДЫ: У 80 больных с ХГН в стадии обострения были проведены  детальное клинико-лабораторное обследование, включающее определение VCAM-1 в сыворотке крови методом иммуноферментного анализа и выполнение пункционной  нефробиопсии с оценкой морфологических изменений. Статистический анализ полученных  результатов проводился с помощью программ «Microsoft Office Excel 2010» («Microsoft Corp.», США) и «STATISTICA 10.0» («StatSoft Inc.», США).</p></sec><sec><title>РЕЗУЛЬТАТЫ</title><p>РЕЗУЛЬТАТЫ. Содержание VCAM-1 в сыворотке крови составило 719 [643;771] нг/мл.  Получены статистически значимые взаимосвязи с расширением мезангиального  пространства, набуханием эндотелия, утолщением стенок капилляров, мезангиальной  гиперклеточностью, эндотелиальной гиперклеточностью, наличием белковых цилиндров в  канальцах, сращением капиллярных петель, фиброзными полулуниями, некрозом  подоцитов, гипертрофическим типом ремоделирования сосудов резистивного типа,  депозитами Ig, депозитами IgA, депозитами IgG, свечением С3-компонента комплемента,  отложениями фибриногена.</p></sec><sec><title>ЗАКЛЮЧЕНИЕ</title><p>ЗАКЛЮЧЕНИЕ. Результаты исследования демонстрируют важную роль VCAM-1 в процессе развития иммунокомплексного воспаления при гломерулонефрите. VCAM-1 является  маркером различных морфологических изменений при ХГН, а определение уровня VCAM-1 в  сыворотке крови является информативным, простым и неинвазивным методом, который  позволит оценивать активность воспалительного процесса, прогнозировать риск появления морфологических изменений в структуре почечной ткани у пациентов с ХГН.</p></sec></abstract><trans-abstract xml:lang="en"><p>Chronic glomerulonephritis is characterized by irreversible progression of the pathological process, which leads to the formation of terminal renal failure significantly impairing the  patient's quality of life, leading to internal dysfunction and increasing the risk of premature overall and cardiovascular mortality.  Consequently, the search for non-invasive methods for assessing the state of renal tissue, including the detection of proteins involved  in renal inflammation, fibrosis, intercellular interaction is currently important.</p><sec><title>THE AIM</title><p>THE AIM: To determine the serum levels of the vascular cell adhesion molecule-1 (VCAM-1) in patients with various forms of  chronic glomerulonephritis (CGN) and to clarify its relationship to the  development of morphological changes in the renal tissue.</p></sec><sec><title>PATIENTS AND METHODS</title><p>PATIENTS AND METHODS: In 80 patients (men and women), with CGN in the acute stage was carried out a detailed clinical and  laboratory examination, including determination of serum VCAM-1 by ELISA and performing puncture renal biopsy with the assessment of  morphological changes. Statistical analysis of the results was carried  out using «Microsoft Office Excel 2010» («Microsoft Corp.», USA)  and "STATISTICA 10.0" («StatSoft Inc.», USA).</p></sec><sec><title>RESULTS</title><p>RESULTS. The serum level concentration of VCAM-1 was 719  [643;771] ng/ml. Obtained statistically significant interrelations with  enlargement of mesangial space, endothelial growth, capillary walls  thickening, mesangial hypercellularity, endothelial hypercellularity,  protein casts in tubules, anses capillaries union, fibrose demilunes,  podocyte necrosis, hypertrophic remodeling type of resistive type  vessels, Ig deposites, IgA deposites, IgG seposites, C3 complement  fluorescence, fibrinogen deposites. </p></sec><sec><title>CONCLUSION</title><p>CONCLUSION: The results of the study demonstrate the important  role of VCAM-1 in the development of immunocomplex inflammation in glomerulonephritis. VCAM-1 is a marker of different morphological changes in CGN, and determining the level of VCAM-1 in serum is  informative, simple and noninvasive method which provides  evaluation of inflammatory process activity, prediction of the risk of morphological changes in the renal tissue structure in patients  with CGN.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>хронический гломерулонефрит</kwd><kwd>сосудистая молекула адгезии-1</kwd><kwd>IgA-нефропатия</kwd></kwd-group><kwd-group xml:lang="en"><kwd>chronic glomerulonephritis</kwd><kwd>vascular cell adhesion molecule-1</kwd><kwd>IgA-nephropathy</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Bello AK, Levin A, Tonelli M et al. Assessment of Global Kidney Health Care Status. JAMA 2017;317(18):1864-1881. Doi: 10.1001/jama.2017.4046</mixed-citation><mixed-citation xml:lang="en">Bello AK, Levin A, Tonelli M et al. Assessment of Global Kidney Health Care Status. JAMA 2017;317(18):1864-1881. Doi: 10.1001/jama.2017.4046</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Taylor DM, Fraser SD, Bradley JA et al. A Systematic Review of the Prevalence and Associations of Limited Health Literacy in CKD Clin. J Am Soc Nephrol 2017;12(7):1070- 1084. Doi: 10.2215/CJN.12921216</mixed-citation><mixed-citation xml:lang="en">Taylor DM, Fraser SD, Bradley JA et al. A Systematic Review of the Prevalence and Associations of Limited Health Literacy in CKD Clin. J Am Soc Nephrol 2017;12(7):1070- 1084. Doi: 10.2215/CJN.12921216</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Saran R, Robinson B, Abbott KC et al. US Renal Data System 2017 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis 2018;71(3S1):A7. Doi: 10.1053/j.ajkd.2018.01.002</mixed-citation><mixed-citation xml:lang="en">Saran R, Robinson B, Abbott KC et al. US Renal Data System 2017 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis 2018;71(3S1):A7. Doi: 10.1053/j.ajkd.2018.01.002</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Агранович НВ. Обоснование и эффективность профилактики и лечения больных с хронической болезнью почек в амбулаторнополиклинических условиях. Нефрология 2013;17(5):43-48. https://doi.org/10.24884/1561-6274-2013-17-5-43-48. [Agranovich NV. The rationale and effectiveness of precaution and treatment of chronic kidney diseases patients in out-patient conditions. Nephrology (Saint-Petersburg) 2013;17(5):43-48. (In Russ.) https://doi.org/10.24884/1561-6274-2013-17-5-43-48]</mixed-citation><mixed-citation xml:lang="en">Агранович НВ. Обоснование и эффективность профилактики и лечения больных с хронической болезнью почек в амбулаторнополиклинических условиях. Нефрология 2013;17(5):43-48. https://doi.org/10.24884/1561-6274-2013-17-5-43-48. [Agranovich NV. The rationale and effectiveness of precaution and treatment of chronic kidney diseases patients in out-patient conditions. Nephrology (Saint-Petersburg) 2013;17(5):43-48. (In Russ.) https://doi.org/10.24884/1561-6274-2013-17-5-43-48]</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Левицкая ЕС, Батюшин ММ, Пасечник ДГ, Антипова НВ. Прогнозирование ремоделирования ткани почек с учетом структурных изменений почечных артерий малого диаметра. Нефрология 2016;20(5):55-61 [Levitskaya ES, Batiushin MM, Pasechnik DG, Antipova NV. Prediction of kidney tissue remodeling in view of small small diameter renal arteries structural changes. Nephrology (Saint-Petersburg) 2016;20(5):55-61. (In Russ.)]</mixed-citation><mixed-citation xml:lang="en">Левицкая ЕС, Батюшин ММ, Пасечник ДГ, Антипова НВ. Прогнозирование ремоделирования ткани почек с учетом структурных изменений почечных артерий малого диаметра. Нефрология 2016;20(5):55-61 [Levitskaya ES, Batiushin MM, Pasechnik DG, Antipova NV. Prediction of kidney tissue remodeling in view of small small diameter renal arteries structural changes. Nephrology (Saint-Petersburg) 2016;20(5):55-61. (In Russ.)]</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Mallamaci F. Highlights of the 2015 ERA-EDTA congress: chronic kidney disease, hypertension. Nephrol Dial Transplant 2016;31(7):1044-6. Doi: 10.1093/ndt/gfw006</mixed-citation><mixed-citation xml:lang="en">Mallamaci F. Highlights of the 2015 ERA-EDTA congress: chronic kidney disease, hypertension. Nephrol Dial Transplant 2016;31(7):1044-6. Doi: 10.1093/ndt/gfw006</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Duffield JS. Cellular and molecular mechanisms in kidney fibrosis. J Clin Invest 2014;124(6):2299-306. Doi: 10.1172/JCI72267</mixed-citation><mixed-citation xml:lang="en">Duffield JS. Cellular and molecular mechanisms in kidney fibrosis. J Clin Invest 2014;124(6):2299-306. Doi: 10.1172/JCI72267</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: testing and clinical relevance. Circulation 2007;15, pp. 12-18</mixed-citation><mixed-citation xml:lang="en">Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: testing and clinical relevance. Circulation 2007;15, pp. 12-18</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Mudrovcic N, Arefin S, Van Craenenbroeck A, Kublickiene K. Endothelial maintenance in health and disease: Importance of sex differences. Pharmacol Res 2017 May;119:48-60. Doi: 10.1016/j.phrs.2017.01.011</mixed-citation><mixed-citation xml:lang="en">Mudrovcic N, Arefin S, Van Craenenbroeck A, Kublickiene K. Endothelial maintenance in health and disease: Importance of sex differences. Pharmacol Res 2017 May;119:48-60. Doi: 10.1016/j.phrs.2017.01.011</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Chen J, Hamm LL, Mohler ER et al. Interrelationship of Multiple Endothelial Dysfunction Biomarkers with Chronic Kidney Disease. PLoS One 2015;10(7):e0132047. doi: 10.1371/journal.pone.0132047. eCollection 2015</mixed-citation><mixed-citation xml:lang="en">Chen J, Hamm LL, Mohler ER et al. Interrelationship of Multiple Endothelial Dysfunction Biomarkers with Chronic Kidney Disease. PLoS One 2015;10(7):e0132047. doi: 10.1371/journal.pone.0132047. eCollection 2015</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Barreto DL, Coester AM, Heijne A et al. Soluble VCAM-1 and E-Selectin in PD Patients: The Additive Value of the Free Diffusion Coefficient in the Assessment of Local Peritoneal Production. Perit Dial Int 2015;35(1):90-93. Doi: 10.3747/pdi.2013.00015</mixed-citation><mixed-citation xml:lang="en">Barreto DL, Coester AM, Heijne A et al. Soluble VCAM-1 and E-Selectin in PD Patients: The Additive Value of the Free Diffusion Coefficient in the Assessment of Local Peritoneal Production. Perit Dial Int 2015;35(1):90-93. Doi: 10.3747/pdi.2013.00015</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Zhu L, Shi S, Liu L et al. Increased plasma sVCAM-1 is associated with severity in IgA nephropathy. BMC Nephrol 2013;14:21. Doi: 10.1186/1471-2369-14-21</mixed-citation><mixed-citation xml:lang="en">Zhu L, Shi S, Liu L et al. Increased plasma sVCAM-1 is associated with severity in IgA nephropathy. BMC Nephrol 2013;14:21. Doi: 10.1186/1471-2369-14-21</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Polat Sefika Burcak, Ugurlu Nagihan, Aslan Nabi, Cuhaci Neslihan, Ersoy Reyhan, Cakir Bekir. Evaluation of biochemical and clinical markers of endothelial dysfunction and their correlation with urinary albumin excretion in patients with type 1 diabetes mellitus. Arch Endocrinol Metab [Internet] 2016 Apr [cited 2018 Aug 22]; 60(2): 117-124. Available from: http://www.scielo.br/scielo.php?script=sci_arttext&amp;pid=S2359-39972016000200117&amp;lng=en. Epub Feb 16, 2016. http://dx.doi.org/10.1590/2359-3997000000116</mixed-citation><mixed-citation xml:lang="en">Polat Sefika Burcak, Ugurlu Nagihan, Aslan Nabi, Cuhaci Neslihan, Ersoy Reyhan, Cakir Bekir. Evaluation of biochemical and clinical markers of endothelial dysfunction and their correlation with urinary albumin excretion in patients with type 1 diabetes mellitus. Arch Endocrinol Metab [Internet] 2016 Apr [cited 2018 Aug 22]; 60(2): 117-124. Available from: http://www.scielo.br/scielo.php?script=sci_arttext&amp;pid=S2359-39972016000200117&amp;lng=en. Epub Feb 16, 2016. http://dx.doi.org/10.1590/2359-3997000000116</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Tomino Y. Pathogenesis and Treatment of Chronic Kidney Disease: A Review of Our Recent Basic and Clinical Data. Kidney Blood Press Res 2014;39(5):450-489. Doi: 10.1159/000368458</mixed-citation><mixed-citation xml:lang="en">Tomino Y. Pathogenesis and Treatment of Chronic Kidney Disease: A Review of Our Recent Basic and Clinical Data. Kidney Blood Press Res 2014;39(5):450-489. Doi: 10.1159/000368458</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
